Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
David Camp investment portfolio
David Camp has made numerous investments in companies such as Accession Therapeutics within the Biotech sector.
Portfolio
1
Team
0
Shareholding changes (3)
David Camp's positions across portfolio companies2025
- ORDINARY 9,069 → 15,348
2024
- ORDINARY 2,790 → 9,069
Articles (1)
- Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies26 Mar 2026Accession Therapeutics